Pear Therapeutics (Nasdaq:PEAR) stock is down today — a day after it reported mixed third-quarter results.
The Boston-based prescription digital therapeutic (PDT) developer also announced a large set of layoffs yesterday evening. The new layoffs follow a previous workforce reduction announced over the summer.
Shares of PEAR were down more than 3% at $2.44 apiece by midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up more than 6%.
Get the full story at our sister site, Drug Delivery Business News.
This story originally ran on Nov. 14, 2022. Updated Nov. 15 with the next-day stock price.
